AGM
IDXX icon

Alpine Global Management’s Idexx Laboratories IDXX Stock Holding History

Alpine Global Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,152
Closed -$234K – 139
2015
Q3 		$234K Buy
+3,152
New +$226K 0.07% 71

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Alpine Global Management's IDXX Position: Q4 2015 in Review

Alpine Global Management sold out of Idexx Laboratories (IDXX) in Q4 2015, closing a stake of 3,152 shares — an estimated $234K sold.

Alpine Global Management first reported a position in IDXX in Q3 2015 and held it in 1 quarter. The position peaked at $234K in Q3 2015. 350 funds tracked by Wall St. Rank hold IDXX as of Q4 2015.

  • Alpine Global Management reported no remaining Idexx Laboratories position as of Q4 2015 after selling out during the quarter.
  • Alpine Global Management sold 3,152 Idexx Laboratories shares in Q4 2015, an estimated $234K.
  • Alpine Global Management first reported a position in Idexx Laboratories in Q3 2015 and held it in 1 quarter.
  • Alpine Global Management's Idexx Laboratories position peaked at $234K in Q3 2015.
  • 350 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2015.

Based on Alpine Global Management's 13F filing for Q4 2015, filed 12 Feb 2016.